Notre Dame researcher’s paper examines the biology and clinical application of tumor-derived microvesicles

Author: William G. Gilroy

"Genes and Development," June 15, 2012

A new paper by Crislyn D’Souza-Schorey, professor of biological sciences at the University of Notre Dame, discusses the biology of tumor-derived microvesicles and their clinical application as circulating biomarkers. Microvesicles are membrane-bound sacs released by tumor cells and can be detected in the body fluids of cancer patients.

The new paper discusses the potential of microvesicles to present a combination of disease- and tissue-specific markers that would constitute a unique and identifiable biosignature for individual cancers.

Read More

Notre Dame joins Indiana medical research initiative

Author: William G. Gilroy

ictsi_rel.jpg

The University of Notre Dame has been accepted as a formal partner in the Indiana Clinical and Translational Sciences Institute (ICTSI), a medical research initiative designed to systematically transform medical discoveries into improved patient care and business opportunities.

The National Institutes of Health (NIH) awarded a five-year Clinical and Translational Science Award (CTSA) of $25 million to the Indiana University School of Medicine in mid-2008 to fund CTSI activities at IU and Purdue University. The NIH created the clinical and translational awards program in an effort to improve the process by which the laboratory discoveries of basic science are transformed into new medical treatments and products — a process called translational research.

Read More